<DOC>
	<DOCNO>NCT01098292</DOCNO>
	<brief_summary>The Control Study Multidisciplinary Approach Study Chronic Pelvic Pain ( MAPP ) Research Network establish focus broad approach study Interstitial Cystitis ( IC ) /Painful Bladder Syndrome ( PBS ) men woman , Chronic Prostatitis ( CP ) /Chronic Pelvic Pain Syndrome ( CPPS ) men , previously undertake . Participants Urologic Pelvic Pain Syndromes well participant specific condition ( Fibromyalgia ( FM ) , Irritable Bowel Syndrome ( IBS ) , Chronic Fatigue Syndrome ( CFS ) ) recruit Trans-MAPP Control Study . These participant act reference/control group Trans-MAPP Epidemiology &amp; Phenotyping ( EP ) Study . As many chronic pain disorder , IC CP poorly understand , treatment often helpful . The goal study well understand pain felt people IC CP . The MAPP Control Study observational study enroll participant 6 Discovery Sites 3 Satellite Sites across U.S . The investigator ask question gather information health life participant research purpose . The investigator hope study lead improvement treatment IC CP .</brief_summary>
	<brief_title>Observational Study Control Participants MAPP Research Network</brief_title>
	<detailed_description>Trans-MAPP Control participant need complete one study visit collect baseline data biospecimens . Potential participant schedule eligibility screen session . Following screening , potentially eligible participant complete baseline phenotyping session , biospecimen collection , together expect take approximately 2.5 hour complete . Participants provide break need clinic visit .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Fatigue Syndrome , Chronic</mesh_term>
	<criteria>The eligibility criterion healthy control positive control base set criterion Urologic Chronic Pelvic Pain Syndrome ( UCPPS ) participant TransMAPP EP Study , exception additional criterion exclude chronic pelvic pain symptom criterion identify comorbid syndrome positive control . All entry criterion show ; specific either healthy positive control participant indicate . Participants eligible TransMAPP Control Protocol meet follow general genderspecific criterion list : 1 . Participant sign dated appropriate Informed Consent document . 2 . Agreed participate TransMAPP Control Study procedure ; Inclusion Criteria Healthy Controls 1 . Participant report response `` 0 '' ( zero ) pain , pressure discomfort scale . 2 . Participant report chronic pain pelvic bladder region , report chronic pain one body region . 3 . Participant report urological symptom evaluate , still present . Inclusion Criteria Positive Controls : 1 . Participant meet validate criterion one follow condition 1 . Fibromyalgia ( FM ) 2 . Irritable bowel syndrome ( IBS ) 3 . Chronic fatigue syndrome ( CFS ) Individuals eligible enrollment TransMAPP Control Study meet criterion : 1 . Participant ongoing symptomatic urethral stricture . 2 . Participant ongoing neurological disease disorder affect bladder bowel fistula . 3 . Participant history cystitis cause tuberculosis radiation therapy Cytoxan/cyclophosphamide therapy . 4 . Participant augmentation cystoplasty cystectomy . 5 . Participant systemic autoimmune disorder ( Crohn 's Disease , Ulcerative Colitis , Lupus , Rheumatoid Arthritis , Multiple Sclerosis ) . 6 . Participant history cancer ( exception skin cancer ) . 7 . Participant current major psychiatric disorder psychiatric medical issue would interfere study participation ( e.g . dementia , psychosis , upcoming major surgery , etc ) . 8 . Participant severe cardiac , pulmonary , renal , hepatic disease judgment study physician would preclude participation study . Exclusion Criteria Males Only 1 . Male participant diagnose unilateral orchialgia , without pelvic symptom . 2 . Male participant history transurethral microwave thermotherapy ( TUMT ) , transurethral needle ablation ( TUNA ) , balloon dilation , prostate cryosurgery laser procedure . Exclusion Criteria Females Only : 1 ) Female participant history HighGrade Squamous Intraepithelial Lesion ( HGSIL ) / highgrade cervical dysplasia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Fibromyalgia</keyword>
	<keyword>Irritable Bowel Syndrome</keyword>
	<keyword>Chronic Fatigue Syndrome</keyword>
	<keyword>Interstitial Cystitis</keyword>
	<keyword>Chronic Prostatitis</keyword>
	<keyword>Urological Chronic Pelvic Pain</keyword>
	<keyword>Painful Bladder Syndrome</keyword>
</DOC>